Rho Hires Global VP of Quality Assurance to Support International Expansion following Acquisition

Epic Selects Lyniate for Integration within the Epic Garden Plot Offering

Novel drug from Neuro-Bio effective in a mouse model of Alzheimer's Disease

Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease.

PubHive Integrates Unpaywall Into PubHive Navigator

Cloud software platform PubHive Navigator saves time for life science teams by expanding journal article access via the platform’s research literature workflow module Fetch

Alfa Chemistry Refreshed Its Website for the Supply of MOF Chemicals

Earlier this year, Alfa Chemistry, a well-established chemical supplier based in New York, announced its decision to further optimize its supply of MOF chemicals, a new material that has huge potentials in fields like gas storage, separation, and catalysis. Now the company has completed the website refresh work and introduced a new brand logo. All these efforts are made in the hope of bringing better customer experience and more convenient website searching.

CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects

Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.

Summarization of the POC Blood Gas and Electrolyte, including the initiatives undertaken by the organizations for its improvisation

Global POC Blood Gas and Electrolyte Market share accounted for up to US$1.95 Bn. It is predicted to reach approximately US$3.6 Bn by 2028, with a steady CAGR of 7.89% throughout the time frame of 2020-2028.

Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV).

Zelis Announces New Chief Marketing Officer, Heather Valteris, International Brand Builder and Strategist for Fortune 100 Companies

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Creative Peptides Announces Innovative Services of Peptide Drug Discovery

Creative Peptides announces the release of innovative peptide drug discovery services to support and assist global clients in winning the race of peptide drug development.

Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific Hybridization

Creative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.

Useful Approaches for Labeling Peptides with Fluorescent Dyes

Creative Peptides provides useful approaches for labeling peptides with fluorescent dyes

Lyniate and NextGate Announce Merger Agreement, Advancing Healthcare Interoperability Leadership

Lyniate and NextGate have entered into a merger agreement.

ProteoGenix Launches New XtenCHO Transient CHO Expression System to Improve Biologics Development

ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System.

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal March 14, 2022 - North Carolina-based Triangle Business Journal recently unveiled the winners of its 2022 class of Health Care Leadership Awards, naming Rho as one of this year’s honorees. The global, full-service contract research organization (CRO) was chosen from a pool of Triangle-area nominees that work in a number of health care settings, including major hospital systems, small physician groups, life sciences firms and nonprofit health charities. "The honorees of this year’s Health Care Leadership Awards are making a significant impact on the quality of health care in the Triangle region," said Jason Christie, market president and publisher of TBJ. "This year’s honorees really are heroes in our community. Triangle Business Journal is pleased to honor them.”

Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions

Curebase Rapidly Reaches Growth Milestone

Decentralized Clinical Trial Platform Provider Welcomes 100th Teammate

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities